Antibodies against a putative heparin receptor slow cell proliferation and decrease MAPK activation in vascular smooth muscle cells.

Antibodies against a putative heparin receptor slow cell proliferation and decrease MAPK activation in vascular smooth muscle cells.

Item
http://www.wikidata.org/entity/Q43586666
Transmembrane Protein 184A Is a Receptor Required for Vascular Smooth Muscle Cell Responses to HeparinMolecular regulation of contractile smooth muscle cell phenotype: implications for vascular tissue engineering.Bivalirudin in combination with heparin to control mesenchymal cell procoagulant activity.Heparin Decreases in Tumor Necrosis Factor α (TNFα)-induced Endothelial Stress Responses Require Transmembrane Protein 184A and Induction of Dual Specificity Phosphatase 1.The effects of heparin releasing hydrogels on vascular smooth muscle cell phenotype.Disruption of cell-matrix interactions by heparin enhances mesenchymal progenitor adipocyte differentiation.The human hyaluronan receptor for endocytosis (HARE/Stabilin-2) is a systemic clearance receptor for heparinActive stress kinases in proliferating endothelial cells associated with cytoskeletal structures.Heparin responses in vascular smooth muscle cells involve cGMP-dependent protein kinase (PKG)Heparin and fibroblast growth factors affect surfactant protein gene expression in type II cells.Heparin treatment of vascular smooth muscle cells results in the synthesis of the dual-specificity phosphatase MKP-1.Inhibitory effects of glycosaminoglycans on basal and stimulated transforming growth factor-β1 expression in mesangial cells: biochemical and structural considerations.
P2860

Antibodies against a putative heparin receptor slow cell proliferation and decrease MAPK activation in vascular smooth muscle cells.

Item
http://www.wikidata.org/entity/Q43586666
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Antibodies against a putative ...... vascular smooth muscle cells.
@en
Antibodies against a putative ...... vascular smooth muscle cells.
@nl
type
label
Antibodies against a putative ...... vascular smooth muscle cells.
@en
Antibodies against a putative ...... vascular smooth muscle cells.
@nl
prefLabel
Antibodies against a putative ...... vascular smooth muscle cells.
@en
Antibodies against a putative ...... vascular smooth muscle cells.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Antibodies against a putative ...... vascular smooth muscle cells.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921